drugset

drugset / Trial / NCT01104246

Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men

NCT01104246 ↗

Phase 1 Completed 40 enrolled Watson Pharmaceuticals

NaSingle-groupOpen-labelTreatment

Summary

The study will evaluate the pharmacokinetics of testosterone transdermal systems at steady-state in hypogonadal men.

Timeline

Start: 2010-04
Primary completion: 2010-09
Completion: 2010-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Testosterone	Small molecule	—	Other

Indications